Study Title
INTACT-TAA: A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia
Protocol ID
INTACT-TAA
Condition/s
Acute Myelocytic Leukemia (AML)
Diagnosis Stage
Relapse/ refractory
Sponsor
University of Sydney
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 Year to 70 Years
International registry ID's
NCT02895412
| Study Title | INTACT-TAA: A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia |
|---|---|
| Protocol ID | INTACT-TAA |
| Disease (Sub Disease) | Acute Myelocytic Leukemia (AML) |
| Diagnosis Stage | Relapse/ refractory |
| Sponsor | University of Sydney |
| Links | https://clinicaltrials.gov/ct2/show/NCT02895412 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 01/03/2017 |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | 1 Year to 70 Years |
| International registry ID's | NCT02895412 |